enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. How a new FDA-approved drug can — and can’t - AOL

   www.aol.com/fda-approved-drug-t-help-121600044.html

   In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...

3. Anti-amyloid drugs - Wikipedia

   en.wikipedia.org/wiki/Anti-amyloid_drugs

   Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

4. Age-related illnesses and treatment options - AOL

   www.aol.com/age-related-illnesses-treatment...

   Two commonly prescribed medications to treat Alzheimer's are cholinesterase inhibitors (Aricept, Razadyne, Exelon) and memantine . However, these drugs don't work for everyone. However, these ...

5. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

   www.aol.com/revolutionary-alzheimer-drug-just...

   Alzheimer’s drug Leqembi, the first medicine shown to slow the disease, has earned FDA approval. Learn more about the treatment and what this means for patients.

6. Aducanumab - Wikipedia

   en.wikipedia.org/wiki/Aducanumab

   Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.

7. Anti-amyloid antibodies - Wikipedia

   en.wikipedia.org/wiki/Anti-amyloid_antibodies

   Aducanumab, sold under the brand name Aduhelm, is an anti-amyloid drug designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...